These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3303155)

  • 1. [Fatty liver and obesity].
    Kucio C; Waluga M; Zahorska-Markiewicz B
    Przegl Lek; 1987; 44(3):341-4. PubMed ID: 3303155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology of lipid metabolism and liver changes in obesity].
    Cotrozzi G; Relli P; Cersosimo R; Venturi M; Rossi M
    Clin Ter; 1995; 146(8-9):483-90. PubMed ID: 8536431
    [No Abstract]   [Full Text] [Related]  

  • 3. TNF-alpha is not the cause of fatty liver disease in obese diabetic mice.
    Memon RA; Grunfeld C; Feingold KR
    Nat Med; 2001 Jan; 7(1):2-3. PubMed ID: 11135585
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatty liver--current look at the old disease.
    Mach T
    Med Sci Monit; 2000; 6(1):209-16. PubMed ID: 11208312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and nutritional considerations in nonalcoholic fatty liver.
    Fong DG; Nehra V; Lindor KD; Buchman AL
    Hepatology; 2000 Jul; 32(1):3-10. PubMed ID: 10869282
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lesions of the liver in patients with alimentary-constitutional morbid obesity].
    Romanov MM; Kuzin NM; Lebedev SP; Markov VK; Rodina LF; Brimas GE
    Klin Med (Mosk); 1989 Nov; 67(11):14-20. PubMed ID: 2696832
    [No Abstract]   [Full Text] [Related]  

  • 7. [Obesity as a risk factor in hepatobiliary diseases].
    Oguma M; Harada T
    Nihon Rinsho; 1988 Nov; 46(11):2443-7. PubMed ID: 3241367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fatty liver in obesity].
    Ishii M; Toyata T
    Ryoikibetsu Shokogun Shirizu; 1995; (8):32-4. PubMed ID: 8581641
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intestinal shunt operation in the treatment of obesity].
    Streuli HK
    Helv Chir Acta; 1972 Dec; 39(5):823-5. PubMed ID: 4652346
    [No Abstract]   [Full Text] [Related]  

  • 10. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice.
    Bigorgne AE; Bouchet-Delbos L; Naveau S; Dagher I; Prévot S; Durand-Gasselin I; Couderc J; Valet P; Emilie D; Perlemuter G
    Gastroenterology; 2008 May; 134(5):1459-69. PubMed ID: 18471520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].
    Crespo J; Cayón A; Pons-Romero F
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():15-23. PubMed ID: 15195530
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism during lactation: a review of adipose tissue-liver interactions and the development of fatty liver.
    Vernon RG
    J Dairy Res; 2005 Nov; 72(4):460-9. PubMed ID: 16223462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of nonalcoholic fatty liver disease: insights from children and mice.
    Ahima RS
    Gastroenterology; 2008 Dec; 135(6):1860-2. PubMed ID: 19000676
    [No Abstract]   [Full Text] [Related]  

  • 15. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients.
    Elizondo A; Araya J; Rodrigo R; Poniachik J; Csendes A; Maluenda F; Díaz JC; Signorini C; Sgherri C; Comporti M; Videla LA
    Obesity (Silver Spring); 2007 Jan; 15(1):24-31. PubMed ID: 17228028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-alcoholic fatty liver--life of overindulgence with fatty liver].
    Füessl HS
    MMW Fortschr Med; 2005 Jun; 147(25):4-6, 8. PubMed ID: 16038330
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS; Riely CA; Madan AK
    Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty metamorphosis of the liver in morbid obesity.
    Kern WH; Heger AH; Payne JH; DeWind LT
    Arch Pathol; 1973 Nov; 96(5):342-6. PubMed ID: 4741905
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatty changes in the liver: the relation to age, overweight and diabetes mellitus.
    Hornbøll P; Olsen TS
    Acta Pathol Microbiol Immunol Scand A; 1982 May; 90(3):199-205. PubMed ID: 7102315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.